Putnam Associates is a premier strategy consulting firm serving biopharmaceutical, diagnostics, and medical device clients, and the private equity / venture capital community. For 30 years, we have offered objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle.
January 26, 2021 Boston, MA: Putnam Associates, part of Ashfield Advisory, announces that PHMR Limited, a global consulting firm specializing in market access and health economics outcomes research (HEOR), will join Putnam’s Value, Pricing and Access practice area. PHMR specializes in health economics, real world evidence, patient reported outcomes, health technology assessments and other HEOR activitiesread more
January 13, 2020 BOSTON, MA; SAN FRANCISCO, CA; NEW YORK, NY; LONDON, UK Putnam has once again earned a spot in the 2021 Vault Consulting Rankings! We’re proud to be ranked as one of the 50 best consulting firms to work for in North America. Among all consulting firms surveyed, Putnam Associates ranked #10 overall,read more
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.